MiR-449a promotes breast cancer progression by targeting CRIP2-Reference-Cited by-同舟云学术

MiR-449a promotes breast cancer progression by targeting CRIP2

Published:2016-02-26 Issue:14 Volume:7 Page:18906-18918
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Shi Wei¹,Bruce Jeff¹,Lee Matthew¹,Yue Shijun¹,Rowe Matthew¹,Pintilie Melania²,Kogo Ryunosuke¹,Bissey Pierre-Antoine¹,Fyles Anthony³⁴,Yip Kenneth W.¹,Liu Fei-Fei¹³⁴⁵

Affiliation:

1. Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

2. Division of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

3. Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Canada

4. Department of Radiation Oncology, University of Toronto, Toronto, Canada

5. Department of Medical Biophysics, University of Toronto, Toronto, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer;Cell Death Discovery;2024-08-22

2. The Overexpressed MicroRNAs miRs-182, 155, 493, 454, and U6 snRNA and Underexpressed let-7c, miR-328, and miR-451a as Potential Biomarkers in Invasive Breast Cancer and Their Clinicopathological Significance;Oncology;2024-08-12

3. miR‐449a: A Promising Biomarker and Therapeutic Target in Cancer and Other Diseases;Cell Biochemistry and Biophysics;2024-05-29

4. MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer;2024-04-24

5. MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer;Molecular Therapy - Nucleic Acids;2024-03